{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:32:22Z","timestamp":1785367942119,"version":"3.55.0"},"reference-count":21,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"INSERM UMRS-1172 research unit"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease with diverse clinical phenotypes, prompting the development of new diagnostic criteria known as the MDS-PSP classification. However, little is known about the prognostic value of this classification in order to better stratify patients for the clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the impact of the different clinical phenotypes according to the MDS-PSP classification on prognosis using the clinical milestones of death, severe dysphagia, institutionalization, and need for walking aid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective cohort of 205 PSP patients from Lille University Hospital was analyzed retrospectively. Patients were classified into different MSD-PSP phenotypes according to their clinical presentation after 3 years of follow-up. The milestones of death, severe dysphagia, institutionalization, and need for walking aid were recorded, and a survival analysis was performed to describe the prognosis of each disease presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median survival time was 6.4 (interquartile range (IQR): 4.8\u20138.6) years and mean diagnostic delay from symptom onset was 38.1\u2009\u00b1\u200922.5 months. PSP Richardson Syndrome (PSP-RS) had a poorer survival rate and a higher occurrence of severe dysphagia and need for walking aid compared to PSP variants such as PSP Parkinsonism (PSP-P), PSP postural instability without ocular motor dysfunction (PSP-PI), and other rare phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PSP-RS has a less favorable prognosis compared to PSP variants stratified according to the MDS-PSP classification. This classification could assist in selecting patients for clinical trials and help design outcomes that account for the disease heterogeneity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x241291996","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T18:41:34Z","timestamp":1733683294000},"page":"1652-1658","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3218-5092","authenticated-orcid":false,"given":"F\u00e9lix","family":"Marchand","sequence":"first","affiliation":[{"name":"Neurology, Movement Disorders Department and Memory Center, CHU Lille, Licend, Lille, France"},{"name":"Univ. Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neurosciences &amp; Cognition, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1731-3009","authenticated-orcid":false,"given":"Anne-Sophie","family":"Blaise","sequence":"additional","affiliation":[{"name":"Neurology, Movement Disorders Department and Memory Center, CHU Lille, Licend, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Defebvre","sequence":"additional","affiliation":[{"name":"Neurology, Movement Disorders Department and Memory Center, CHU Lille, Licend, Lille, France"},{"name":"Univ. Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neurosciences &amp; Cognition, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Cailliau","sequence":"additional","affiliation":[{"name":"Biostatistics Department, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-1833","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Bombois","sequence":"additional","affiliation":[{"name":"Neurology, Movement Disorders Department and Memory Center, CHU Lille, Licend, Lille, France"},{"name":"Univ. Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neurosciences &amp; Cognition, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Devos","sequence":"additional","affiliation":[{"name":"Neurology, Movement Disorders Department and Memory Center, CHU Lille, Licend, Lille, France"},{"name":"Univ. Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neurosciences &amp; Cognition, Lille, France"},{"name":"Department of Medical Pharmacology, CHU Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5683-2709","authenticated-orcid":false,"given":"Caroline","family":"Moreau","sequence":"additional","affiliation":[{"name":"Neurology, Movement Disorders Department and Memory Center, CHU Lille, Licend, Lille, France"},{"name":"Univ. Lille, INSERM, CHU Lille, U1172 - LilNCog - Lille Neurosciences &amp; Cognition, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,12,8]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1964.00460160003001"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1377058"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.1"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09324-x"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.4347"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.06.014"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002638"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314956"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324903"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27666"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.01.015"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab206"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26054"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh488"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad105"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_611_20"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30157-6"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00888-5"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm032"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.07.010"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241291996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X241291996","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X241291996","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:07:32Z","timestamp":1780682852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X241291996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1177\/1877718X241291996"],"URL":"https:\/\/doi.org\/10.1177\/1877718x241291996","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}